Oramed Letter to Shareholders
/PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of...
Source: prnewswire.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Achieved Primary. Real-time updates on events, politics, business and more.